Norio Yasui-Furukori
Department of Neuropsychiatry
Hirosaki University Graduate School of Medicine
Hirosaki
Japan
Name/email consistency: high
- No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics. Yasui-Furukori, N., Fujii, A., Sugawara, N., Tsuchimine, S., Saito, M., Hashimoto, K., Kaneko, S. Hum. Psychopharmacol (2012)
- Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders. Yasui-Furukori, N., Nakagami, T., Kaneda, A., Inoue, Y., Suzuki, A., Otani, K., Kaneko, S. Hum. Psychopharmacol (2011)
- Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia. Yasui-Furukori, N., Saito, M., Nakagami, T., Sugawara, N., Sato, Y., Tsuchimine, S., Furukori, H., Kaneko, S. Prog. Neuropsychopharmacol. Biol. Psychiatry (2010)
- Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients. Yasui-Furukori, N., Furukori, H., Sugawara, N., Tsuchimine, S., Fujii, A., Inoue, Y., Kaneko, S. Hum. Psychopharmacol (2010)
- Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. Yasui-Furukori, N., Furukori, H., Sugawara, N., Fujii, A., Kaneko, S. J. Clin. Psychopharmacol (2010)
- No association between polymorphism in tyrosine hydroxylase and personality traits in healthy Japanese subjects. Tsuchimine, S., Yasui-Furukori, N., Kaneda, A., Saito, M., Nakagami, T., Sugawara, N., Kaneko, S. Psychiatry Clin. Neurosci. (2010)
- Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients. Yasui-Furukori, N., Saito, M., Nakagami, T., Furukori, H., Suzuki, A., Kondo, T., Kaneko, S. J. Psychopharmacol. (Oxford) (2010)
- Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine. Yasui-Furukori, N., Sato, Y., Furukori, H., Saito, M., Nakagami, T., Kaneko, S. J. Clin. Psychiatry (2009)
- Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients. Yasui-Furukori, N., Saito, M., Tsuchimine, S., Nakagami, T., Sato, Y., Sugawara, N., Kaneko, S. Prog. Neuropsychopharmacol. Biol. Psychiatry (2008)
- Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients. Yasui-Furukori, N., Tsuchimine, S., Saito, M., Nakagami, T., Sato, Y., Kaneko, S. Prog. Neuropsychopharmacol. Biol. Psychiatry (2007)
- Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese. Yasui-Furukori, N., Kaneda, A., Iwashima, K., Saito, M., Nakagami, T., Tsuchimine, S., Kaneko, S. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2007)
- Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters. Yasui-Furukori, N., Saito, M., Niioka, T., Inoue, Y., Sato, Y., Kaneko, S. Ther. Drug. Monit (2007)
- Different serum concentrations of steady-state valproic acid in two sustained-release formulations. Yasui-Furukori, N., Saito, M., Nakagami, T., Niioka, T., Sato, Y., Fujii, A., Kaneko, S. Psychiatry Clin. Neurosci. (2007)
- Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects. Yasui-Furukori, N., Saito, M., Inoue, Y., Niioka, T., Sato, Y., Tsuchimine, S., Kaneko, S. Eur. J. Clin. Pharmacol. (2007)
- Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study. Yasui-Furukori, N., Saito, M., Nakagami, T., Kaneda, A., Tateishi, T., Kaneko, S. Prog. Neuropsychopharmacol. Biol. Psychiatry (2006)
- Digitalis intoxication induced by paroxetine co-administration. Yasui-Furukori, N., Kaneko, S. Lancet (2006)
- Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. Yasui-Furukori, N., Uno, T., Sugawara, K., Tateishi, T. Clin. Pharmacol. Ther. (2005)
- Determination of fluvoxamine and its metabolite fluvoxamino acid by liquid-liquid extraction and column-switching high-performance liquid chromatography. Yasui-Furukori, N., Inoue, Y., Kaneko, S., Otani, K. J. Pharm. Biomed. Anal (2005)
- Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia. Yasui-Furukori, N., Kondo, T., Mihara, K., Inoue, Y., Kaneko, S. Psychopharmacology (Berl.) (2004)
- Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes. Yasui-Furukori, N., Takahata, T., Nakagami, T., Yoshiya, G., Inoue, Y., Kaneko, S., Tateishi, T. Br. J. Clin. Pharmacol (2004)
- Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes. Yasui-Furukori, N., Mihara, K., Takahata, T., Suzuki, A., Nakagami, T., De Vries, R., Tateishi, T., Kondo, T., Kaneko, S. Br. J. Clin. Pharmacol (2004)
- Simultaneous determination of haloperidol and bromperidol and their reduced metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography. Yasui-Furukori, N., Inoue, Y., Chiba, M., Tateishi, T. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2004)
- Establishment of new cloned enzyme donor immunoassays (CEDIA) for haloperidol and bromperidol. Yasui-Furukori, N., Saito, M., Furukori, H., Inoue, Y., Someya, T., Kaneko, S., Tateishi, T. Ther. Drug. Monit (2004)
- Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response. Yasui-Furukori, N., Furukori, H., Nakagami, T., Saito, M., Inoue, Y., Kaneko, S., Tateishi, T. Ther. Drug. Monit (2004)
- Sensitive determination of midazolam and 1'-hydroxymidazolam in plasma by liquid-liquid extraction and column-switching liquid chromatography with ultraviolet absorbance detection and its application for measuring CYP3A activity. Yasui-Furukori, N., Inoue, Y., Tateishi, T. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2004)
- Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam. Yasui-Furukori, N., Takahata, T., Kondo, T., Mihara, K., Kaneko, S., Tateishi, T. Br. J. Clin. Pharmacol (2003)
- Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients. Yasui-Furukori, N., Kondo, T., Mihara, K., Suzuki, A., Inoue, Y., Kaneko, S. J. Clin. Psychopharmacol (2003)
- Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassay. Yasui-Furukori, N., Furukori, H., Saito, M., Inoue, Y., Kaneko, S., Tateishi, T. Ther. Drug. Monit (2003)
- Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection. Yasui-Furukori, N., Furuya, R., Takahata, T., Tateishi, T. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2002)
- The characteristics of side-effects of bromperidol in schizophrenic patients. Yasui-Furukori, N., Kondo, T., Ishida, M., Tanaka, O., Mihara, K., Kaneko, S., Otani, K. Psychiatry Clin. Neurosci. (2002)
- Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia. Yasui-Furukori, N., Kondo, T., Suzuki, A., Mihara, K., Kaneko, S. Psychopharmacology (Berl.) (2002)